Cerity Partners LLC Has $89.41 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Cerity Partners LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 164,538 shares of the medical equipment provider’s stock after purchasing an additional 3,604 shares during the period. Cerity Partners LLC’s holdings in Intuitive Surgical were worth $89,412,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of ISRG. Aaron Wealth Advisors LLC grew its holdings in Intuitive Surgical by 0.8% during the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after acquiring an additional 19 shares during the period. Evergreen Capital Management LLC boosted its position in shares of Intuitive Surgical by 0.5% in the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock worth $2,124,000 after purchasing an additional 20 shares during the last quarter. Rise Advisors LLC grew its stake in shares of Intuitive Surgical by 5.6% during the first quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after purchasing an additional 20 shares during the period. Pinnacle Bancorp Inc. increased its holdings in Intuitive Surgical by 4.1% in the second quarter. Pinnacle Bancorp Inc. now owns 532 shares of the medical equipment provider’s stock valued at $289,000 after purchasing an additional 21 shares during the last quarter. Finally, City Holding Co. increased its holdings in Intuitive Surgical by 16.1% in the second quarter. City Holding Co. now owns 159 shares of the medical equipment provider’s stock valued at $86,000 after purchasing an additional 22 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 1.2%

Intuitive Surgical stock opened at $575.34 on Monday. The company has a 50 day moving average of $518.60 and a 200-day moving average of $505.04. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The stock has a market capitalization of $206.25 billion, a PE ratio of 76.10, a price-to-earnings-growth ratio of 5.29 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm’s revenue was up 22.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.84 EPS. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on ISRG. Rothschild & Co Redburn boosted their target price on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. BTIG Research boosted their price objective on shares of Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, October 31st. Hsbc Global Res raised shares of Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Finally, Piper Sandler boosted their price target on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $607.17.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 3,500 shares of the company’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the transaction, the executive vice president owned 5,758 shares of the company’s stock, valued at $3,310,850. This represents a 37.81% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the transaction, the chief executive officer directly owned 234,256 shares of the company’s stock, valued at $128,266,872.80. This represents a 9.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 108,939 shares of company stock valued at $60,757,995 over the last ninety days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.